DiscoverClinical Chemistry PodcastPost-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use
Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use

Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use

Update: 2025-11-05
Share

Description

Ruben Y Luo, Priscilla S W Yeung, Morgan W Mann, Lichao Zhang, Yifei K Yang, Andrew N Hoofnagle, Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use, Clinical Chemistry, Volume 71, Issue 11, November 2025, Pages 1111–1124, https://doi.org/10.1093/clinchem/hvaf094

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use

Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use

Ruben Y Luo